Point72 Asset Management’s Transmedics TMDX Stock Holding History

Point72 Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$785K	Hold	7,900	–	–	﹤0.01%	2903
2025 Q4	$961K	Buy	+7,900	New	+$991K	﹤0.01%	2896

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management's TMDX Position: Q3 2023 in Review

Point72 Asset Management sold out of Transmedics (TMDX) in Q3 2023, closing a stake of 834 shares — an estimated $70.1K sold.

Point72 Asset Management first reported a position in TMDX in Q2 2020 and held it in 7 quarters. The position peaked at $10.7M in Q2 2021. 221 funds tracked by Wall St. Rank hold TMDX as of Q3 2023.

Point72 Asset Management reported no remaining Transmedics position as of Q3 2023 after selling out during the quarter.
Point72 Asset Management sold 834 Transmedics shares in Q3 2023, an estimated $70.1K.
Point72 Asset Management first reported a position in Transmedics in Q2 2020 and held it in 7 quarters.
Point72 Asset Management's Transmedics position peaked at $10.7M in Q2 2021.
221 funds tracked by Wall St. Rank held Transmedics as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.